Sen­a­tors heap abuse on Al­ler­gan's at­tempt at an end run around patent re­views, of­fer bill to stop 'sham'

Al­ler­gan CEO Brent Saun­ders $AGN ve­he­ment­ly de­fend­ed his move to try and shield the com­pa­ny’s Resta­sis fran­chise by hand­ing its patents over to a Mo­hawk In­di­an tribe as a strike against the in­ter partes re­view process, which the com­pa­ny felt was an in­her­ent­ly un­fair threat to its block­buster drug.

What the com­pa­ny ac­com­plished, though, was to stir up a hor­net’s nest of an­gry law­mak­ers who con­demned the move as a sham. And a bi­par­ti­san group of law­mak­ers heav­i­ly rep­re­sent­ed by Re­pub­li­cans re­tal­i­at­ed this week with a new bill that would pre­vent any­one from try­ing this again.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER